Orange River Wealth LLP opens its private placement of preferential shares in its wholly owned subsidiary Orange River Capital Ltd for qualifying investors enabling participation in its equity purchase of Greengrow Capital Pty, a leading medical cannabis consultancy. Greengrow Capital has established its first medical cannabis cultivation facility under license from the South African Health Products Regulatory Authority (SAHPRA) at El Passo Farms, Pretoria. The facility is already operational and in 2021 becomes revenue producing from its commercial activities after a lengthy period of research and development identifying bespoke genetic strains of cannabis sativa and focussing on specific cannabinoid derivative strengths from the over 100 distinct cannabinoids found in the cannabis plant, particularly THC, THC-V, CBD, CBD-G among others.
Orange River Wealth LLP is a boutique private equity partnership focussing on environmental, social, and ethically responsible investments that truly provide a positive impact for the wider world and its investors.
Managing partner of Orange River Wealth and CEO of Orange River Capital Lee Farbrace, said “We are delighted to bring this outstanding opportunity to our investors. This represents a truly unique entry into what is fast becoming the industry of the decade with medical cannabis providing a plethora of potential health benefits as well as wider world implications in replacing addiction to opiate based medicines. Greengrow has done an outstanding job this far in creating an excellent cultivation facility and under the stewardship of Brylyne has forged enviable relationships globally, not only in the scientific research and development of these ground-breaking treatments but also from a commercial aspect in already securing numerous off take agreements that the facility can now start to supply. Add to this our investment to improve and expand operations we are pleased to welcome on board new preferential shareholders to participate in this very exciting project.”
